Scientific Opinion on the substantiation of health claims related to β-hydroxy β-methylbutyrate monohydrate (HMB) alone or in combination with α-ketoisocaproic acid (KIC) and reduction of muscle tissue damage during exercise (ID 1577, 1584), increase in lean body mass (ID 1579, 1582, 1583), increase in muscle strength (ID 1578, 1583, 1587), increase in endurance performance (ID 1580, 1581), skeletal muscle tissue repair (ID 1586) and faster recovery from muscle fatigue after exercise (ID 1576, 1585) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
Published:
Adopted:
Wiley Online Library
Full article:
Meta data
Keywords
β-hydroxy β-methylbutyrate monohydrate, α-ketoisocaproic acid, HMB, KIC, muscle, strength, endurance, repair, exercise, health claims
On request from
European Commission
Question Number
EFSA-Q-2008-2313
EFSA-Q-2008-2314
EFSA-Q-2008-2315
EFSA-Q-2008-2316
EFSA-Q-2008-2317
EFSA-Q-2008-2318
EFSA-Q-2008-2319
EFSA-Q-2008-2320
EFSA-Q-2008-2321
EFSA-Q-2008-2322
EFSA-Q-2008-2323
EFSA-Q-2008-2324
Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Contact
Abstract
No abstract available
© European Food Safety Authority, 2011